(N) | Change in outcome in the tertile with the greatest relative decrease in WC | (N) | Change in outcome in the tertile with the smallest relative decrease in WC | p Value | |
---|---|---|---|---|---|
6-month f/u (n=344) | |||||
Δ BMI | 114 | −9 | 116 | −3 | <0.001 |
Δ SBP | 109 | −8 | 104 | −2 | 0.025 |
Δ DBP | 109 | −2 | 104 | −1 | 0.283 |
Δ Total cholesterol | 61 | −29 | 36 | −12 | 0.017 |
Δ Triglycerides | 61 | −58 | 36 | −60 | 0.959 |
Δ HDL-cholesterol | 61 | 0 | 36 | 1 | 0.700 |
Δ LDL-cholesterol | 61 | −19 | 34 | −4 | 0.033 |
Δ Tot chol/HDL | 61 | −0.8 | 36 | −0.4 | 0.107 |
Δ Fasting glucose | 60 | −11 | 20 | −10 | 0.835 |
Δ HbA1c | 27 | −1.2 | 40 | −0.3 | 0.006 |
2-year f/u (n=170) | |||||
Δ BMI | 57 | −9 | 57 | −2 | <0.001 |
Δ SBP | 57 | −8 | 57 | −2 | 0.027 |
Δ DBP | 57 | −2 | 57 | −1 | 0.492 |
Δ Total cholesterol | 21 | −7 | 13 | 8 | 0.236 |
Δ Triglycerides | 21 | −59 | 13 | 11 | 0.025 |
Δ HDL-cholesterol | 21 | 17 | 13 | 3 | <0.001 |
Δ LDL-cholesterol | 21 | −12 | 13 | 8 | 0.128 |
Δ Totchol/HDL | 21 | −1.1 | 13 | −0.2 | <0.001 |
Δ Fasting glucose | 20 | −9 | 13 | 6 | 0.005 |
Δ HbA1c | 10 | −0.8 | 12 | −0.4 | 0.208 |
BMI, body mass index; DBP, diastolic blood pressure; f/u, follow-up; HbA1c, glycated hemoglobin; LDL, low-density lipoprotein-cholesterol; SBP, systolic blood pressure; Tot chol/HDL, total cholesterol to HDL-cholesterol ratio; WC, waist circumference.